Jeffrey M. Dayno, Chief Medical Officer at Harmony Biosciences Holdings, Inc. (HRMY), sold 50 shares at $30.00 ($2K) on 2021-07-22, disclosed to the SEC on 2021-07-23.
Scheduled sale ($2k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| HRMY | SELL | 2022-11-04 | $900K | — | Filing → |
| HRMY | SELL | 2022-11-02 | $827K | — | Filing → |
| HRMY | SELL | 2021-10-20 | $1.6M | — | Filing → |